Kobayashi C et al. |
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. |
1989 |
Transplant. Proc. |
pmid:2468254
|
Kuroki H et al. |
Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. |
1989 |
Transplant. Proc. |
pmid:2468255
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Ishibashi M et al. |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay. |
1989 |
Transplant. Proc. |
pmid:2469228
|
Starzl TE et al. |
Liver transplantation: an unfinished product. |
1989 |
Transplant. Proc. |
pmid:2469232
|
Hatanaka H et al. |
FK-506 related compounds produced by Streptomyces tsukubaensis No. 9993. |
1989 |
J. Antibiot. |
pmid:2470720
|
Gschwendt M et al. |
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo. |
1989 |
Immunobiology |
pmid:2471685
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Tocci MJ et al. |
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. |
1989 |
J. Immunol. |
pmid:2472451
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Thomson AW |
FK-506--how much potential? |
1989 |
Immunol. Today |
pmid:2473767
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Aoki M et al. |
[Histological observations of immunosuppressive effects of FK-506 in canine lung allotransplantation]. |
1989 |
Bull Chest Dis Res Inst Kyoto Univ |
pmid:2482787
|
Kay JE and Benzie CR |
T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. |
1989 |
Immunol. Lett. |
pmid:2483716
|
Leonard DK et al. |
Toxicity of FK-506 in human fetal pancreas. |
1989 |
Diabetes |
pmid:2463195
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
Brown Z and Neild GH |
FK-506 and haemolytic uraemic syndrome. |
1990 |
Lancet |
pmid:1689442
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Yamamoto K et al. |
Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. |
1990 |
Immunology |
pmid:1689694
|
Thomson AW |
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689883
|
Zeevi A et al. |
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689884
|
Morris RE et al. |
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689885
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Mazzaferro V et al. |
Studies of the hepatotrophic qualities of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689913
|
Kay JE et al. |
The mechanism of action of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689914
|
Suzuki N et al. |
Effects of a novel immunosuppressive agent, FK506, on human B cell activation. |
1990 |
Clin. Exp. Immunol. |
pmid:1690097
|
McCauley J et al. |
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. |
1990 |
Lancet |
pmid:1690326
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Woo J et al. |
The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. |
1990 |
Scand. J. Immunol. |
pmid:1690915
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Propper DJ et al. |
Low-dose FK 506 inhibits sensitisation after blood transfusions. |
1990 |
Transplant. Proc. |
pmid:1697114
|
Tiebosch A et al. |
Side effects of FK 506 in cynomolgus monkeys: a histopathologic study. |
1990 |
Transplant. Proc. |
pmid:1697115
|
Dammeijer PF et al. |
Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival. |
1990 |
Transplant. Proc. |
pmid:1697116
|
Imai K et al. |
Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1697117
|
Iga C et al. |
Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin. |
1990 |
Transplant. Proc. |
pmid:1697118
|
Deguchi K et al. |
[Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis]. |
1990 |
No To Shinkei |
pmid:1697182
|
Murase N et al. |
Prevention of spontaneous diabetes in BB rats with FK 506. |
1990 |
Lancet |
pmid:1697397
|
Justice RM et al. |
The detection of proline isomerase activity in FK506-binding protein by two-dimensional 1H NMR exchange spectroscopy. |
1990 |
Biochem. Biophys. Res. Commun. |
pmid:1697463
|
Isai H et al. |
FK 506 and orthotopic liver transplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1699329
|
Suzuki S et al. |
In vivo 31P nuclear magnetic resonance findings on heterotopically allografted hearts in rats treated with a novel immunosuppressant, FK506. |
1990 |
Heart Vessels |
pmid:1699922
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|
Pugh-Humphreys RG et al. |
The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. |
1990 |
Immunology |
pmid:1696242
|
Mochizuki M and Kawashima H |
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. |
1990 |
Autoimmunity |
pmid:1717007
|
Ni M et al. |
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. |
1990 |
Autoimmunity |
pmid:1717008
|